Filter
1439
Text search:
drug
regimens
Featured
Recommendations
165
New Publications
351
Language
Document type
No document type
899
Guidelines
219
Studies & Reports
191
Manuals
46
Strategic & Response Plan
31
Fact sheets
23
Training Material
16
Situation Updates
7
Resource Platforms
3
Infographics
3
Online Courses
1
Countries / Regions
India
77
South Africa
45
Global
39
Kenya
38
Tanzania
34
Western and Central Europe
30
Zambia
27
Ethiopia
26
Uganda
25
Eastern Europe
25
Nepal
22
Latin America and the Carribbean
19
Nigeria
18
Malawi
18
Rwanda
17
Namibia
17
Africa
17
Asia
16
Bangladesh
14
Myanmar / Burma
14
Ukraine
13
Ghana
12
Zimbabwe
12
Philippines
12
South–East Asia Region
11
Cambodia
10
Mozambique
10
Lesotho
9
Liberia
8
Russia
8
Sierra Leone
7
Botswana
7
Cameroon
5
Haiti
5
Eswatini/ Swaziland
5
Colombia
5
Georgia
5
Senegal
4
Congo, Democratic Republic of
4
Thailand
4
East and Southern Africa
4
Venezuela
4
Albania
4
USA
3
Pakistan
3
Syria
3
Indonesia
3
Argentina
3
West and Central Africa
3
Western Pacific Region
3
Tajikistan
3
Estonia
3
Vietnam
3
Somalia
2
South Sudan
2
Germany
2
China
2
Brazil
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Bhutan
2
Timor Leste/ East Timor
2
Romania
2
North America
2
Guinea
1
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Gambia
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Peru
1
North Macedonia
1
Bolivia
1
Greece
1
Chile
1
Paraguay
1
North Korea
1
Laos
1
Iran
1
Jamaica
1
Denmark
1
Tunisia
1
Oman
1
Authors & Publishers
Publication Years
Category
Countries
468
Clinical Guidelines
222
Public Health
60
Women & Child Health
52
Capacity Building
31
Key Resources
15
Pharmacy & Technologies
14
Toolboxes
HIV
309
TB
305
NTDs
62
AMR
50
Pharmacy
41
Malaria
31
NCDs
30
COVID-19
23
Mental Health
22
Ebola & Marburg
18
Refugee
18
Polio
11
Conflict
11
Caregiver
7
Disability
6
Rapid Response
6
Natural Hazards
4
Health Financing Toolbox
4
Planetary Health
3
Specific Hazards
2
Global Health Education
2
Social Ethics
2
2.0 Rapid Response
2
Cholera
1
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone refere
...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis
...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty
...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the
...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regi
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread
...
The document discusses the complexities of managing patients with COPD and multiple comorbidities, highlighting the importance of personalized care and the appropriate use of inhaled corticosteroids (ICS). It outlines common comorbidities, such as asthma, osteoporosis, and diabetes, and offers guida
...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce
...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area
...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T
...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S
...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi
...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la
...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t
...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i
...
